Drug composition for enhancing memory of people rapidly exposed to high altitude, and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and memory technology, applied in the field of medicine, can solve the problem of insignificant improvement of memory loss, and achieve the effects of enhancing memory and improving memory
Active Publication Date: 2013-11-20
URUMQI GENERAL HOSPITAL LANZHOU MILITARY AREA CHINESE P L A
View PDF4 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, the above-mentioned anti-altitude hypoxia drugs have no significant effect on improving memory loss caused by acute hypobaric hypoxia.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0018] A pharmaceutical composition for enhancing the memory of people rapidly advancing to high altitudes, including active ingredients taurine, egg yolk lecithin, acetyl-L-carnitine and huperzine A totaling 300 mg; excipients lactose 124 mg, MCC 46 mg, magnesium stearate 8 mg, the active ingredients The ingredients, lactose, and MCC are mixed evenly, moistened with water, the wetted mixture is sieved and dried, sieved, magnesium stearate is added, mixed evenly, and tabletted.
[0019] Active ingredients per unit dosage form: 128mg taurine; 128mg egg yolk lecithin; 44mg acetyl-L-carnitine; 0.8mg huperzine A.
[0020] Prove the beneficial effect of medicine of the present invention below by pharmacodynamics test:
[0021] (1) Materials and methods
[0022] 1. Drugs:
[0023] The prepared pharmaceutical composition of embodiment 1;
[0024] Salidroside, purity >90% (HPLC).
[0025] 2. Screening and grouping of experimental animals:
[0026] Healthy male Sprague-Daw...
Embodiment 2
[0095] A pharmaceutical composition for enhancing the memory of people rapidly advancing to high altitudes, including active ingredients taurine, egg yolk lecithin, acetyl-L-carnitine and huperzine A in total 300 mg; excipients lactose 87 mg, magnesium stearate 5 mg, the active ingredients, The lactose is mixed evenly, moistened with water, the wetted mixture is sieved and dried, sieved, magnesium stearate is added, mixed evenly, and packed into capsules.
[0096] Active ingredients per unit dosage form: 128mg taurine; 128mg egg yolk lecithin; 44mg acetyl-L-carnitine; 0.8mg huperzine A.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The present invention discloses a drug composition for enhancing memory of people rapidly exposed to a high altitude. The drug composition comprises an active component and an auxiliary material, wherein the active component comprises taurine, ovolecithin, acetyl-L-carnitine, and huperzine a, and the auxiliary material comprises lactose, MCC and magnesium stearate, or comprises lactose and magnesium stearate. The drug composition has the following beneficial effects that: based on different mechanisms such as provision of essential nutrients for nerve cells, free radical removing, neurotransmitter acetylcholine precursor complementing, central cholinergic system regulation, and the like, a comprehensive effect is acted on human body, drug combination advantages are presented, and improvement of memory of people rapidly exposed to a high altitude is achieved.
Description
technical field [0001] The invention relates to the field of medicines, in particular to a pharmaceutical composition for enhancing the memory of people rapidly advancing to plateaus and a preparation method thereof. Background technique [0002] After entering the plateau, people living in the plains often cause a series of acute altitude sickness due to low air pressure and hypoxia, including dizziness, palpitation, nausea, insomnia, memory loss and other symptoms. The above symptoms are more obvious. [0003] Both animal model experiments and clinical imaging studies of people rapidly entering high altitudes have shown that acute hypobaric hypoxia can lead to damage to brain hippocampal neurons. On the basis of such pathological changes, people who rapidly enter the plateau may experience cognitive dysfunction, including learning disabilities, memory difficulties, and attention deficits. And eventually lead to a significant decline in the level of vocational skills. ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more